Home - Products - Others - Other Targets - [Ser25] - PKC (19 - 36) Substrate

[Ser25] - PKC (19 - 36) Substrate

CAS No. 113715-84-7

[Ser25] - PKC (19 - 36) Substrate( ——— )

Catalog No. M41668 CAS No. 113715-84-7

[Ser25] - PKC (19 - 36) Substrate

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Ser25] - PKC (19 - 36) Substrate
  • Note
    Research use only, not for human use.
  • Brief Description
    [Ser25] - PKC (19 - 36) Substrate
  • Description
    [Ser25] - PKC (19 - 36) Substrate
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    113715-84-7
  • Formula Weight
    2167.52
  • Molecular Formula
    C93H159N35O25
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tricine

    Tricine can clearly visualize tumors, may as melanoma imaging agents. Using the combination of tricine and a phosphine ligand, HYNIC-derivatized peptides or other small molecules can be labeled with 99mTc in high specific activity and with high stability for potential use as radiopharmaceuticals.

  • 2'-DEOXYCYTIDINE-5'-...

    2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Oxidation contributes to antibiotic lethality in stationary-phase mycobacteria.

  • MI-3454

    MI-3454 is an orally active, selective and potent inhibitor of Menin-MLL1 interaction that inhibits the proliferation and induces differentiation of acute leukemia cells with MLL1 translocation or NPM1 mutation.